CHICAGO, August 18, 2026--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO), an AI-driven precision cardiovascular medicine company, today announced the official launch of its in-house ...
On December 23, 2023, CMS issued its Final Rule, establishing new Clinical Laboratory Improvement Amendments (CLIA) regulations (the Final Rule). Several provisions only became effective December 28, ...
Sysmex America, Inc. announced the introduction of the XR-Series, its next-generation hematology solution, on May 28, 2026. Built around the XR-10 Automated Hematology Module, the platform is designed ...
According to a new report by SNS Insider, the Laboratory Developed Tests Market was valued at USD 12.43 billion in 2023 and is projected to reach USD 23.03 billion by 2032, at a CAGR of 7.11% during ...
Understanding CLIA certification and how it differs from CAP accreditation and ISO 15189 is essential before a sequencing laboratory moves from research into clinical testing, because these frameworks ...
Cardio Diagnostics Begins In-House Test Processing at Its New High Complexity CLIA-Certified Laboratory in Iowa City The new in-house laboratory facility will give Cardio Diagnostics end-to-end ...
The new in-house laboratory facility will give Cardio Diagnostics end-to-end ownership of test processing and expand research capabilities for ongoing and future studies in precision monitoring of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results